{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:36:59Z","timestamp":1792201019488,"version":"4.4.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000395","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T22:31:22Z","timestamp":1240525882000},"page":"e1000395","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":123,"title":["Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1\u2013Associated Dementia"],"prefix":"10.1371","volume":"5","author":[{"given":"Gretja","family":"Schnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Spudich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Swanstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ncl.2008.04.002","article-title":"HIV infection of the central nervous system: clinical features and neuropathogenesis.","volume":"26","author":"L Boisse","year":"2008","journal-title":"Neurol Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS.","volume":"5","author":"F Gonzalez-Scarano","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/157016205774370401","article-title":"Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection.","volume":"3","author":"CL Maslin","year":"2005","journal-title":"Curr HIV Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4049\/jimmunol.156.3.1284","article-title":"Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain.","volume":"156","author":"HS Nottet","year":"1996","journal-title":"J Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1128\/JVI.75.21.10073-10089.2001","article-title":"Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.","volume":"75","author":"PR Gorry","year":"2001","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.3016903","article-title":"Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.","volume":"233","author":"S Koenig","year":"1986","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1742-4690-5-89","article-title":"The V1\u2013V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.","volume":"5","author":"F Rossi","year":"2008","journal-title":"Retrovirology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virol.2006.09.036","article-title":"Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.","volume":"360","author":"ER Thomas","year":"2007","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00002030-200007280-00014","article-title":"Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir\/saquinavir or ritonavir\/saquinavir\/stavudine.","volume":"14","author":"EH Gisolf","year":"2000","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1310\/80JH-148K-NADQ-U927","article-title":"Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.","volume":"4","author":"RJ Pomerantz","year":"2003","journal-title":"HIV Clin Trials"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.280.1.67","article-title":"Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy.","volume":"280","author":"LK Schrager","year":"1998","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.0605513103","article-title":"The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.","volume":"103","author":"RL Dunfee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.virol.2007.05.029","article-title":"Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia.","volume":"367","author":"RL Dunfee","year":"2007","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"12336","DOI":"10.1128\/JVI.77.22.12336-12345.2003","article-title":"Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.","volume":"77","author":"A Ohagen","year":"2003","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/JVI.68.7.4643-4649.1994","article-title":"Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.","volume":"68","author":"C Power","year":"1994","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.54.4.927","article-title":"Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources.","volume":"54","author":"RJ Ellis","year":"2000","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410420503","article-title":"Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.","volume":"42","author":"RJ Ellis","year":"1997","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/00002030-199908200-00008","article-title":"Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.","volume":"13","author":"F Garcia","year":"1999","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1089\/088922200750006010","article-title":"Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.","volume":"16","author":"DW Haas","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/brain\/awl136","article-title":"Genetic attributes of cerebrospinal fluid-derived HIV-1 env.","volume":"129","author":"SK Pillai","year":"2006","journal-title":"Brain"},{"key":"ref21","article-title":"Cross-sectional characterization of HIV-1 <italic>env<\/italic> compartmentalization in cerebrospinal fluid over the full disease course.","author":"PR Harrington"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1128\/JVI.79.16.10830-10834.2005","article-title":"Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1\u2013associated dementia.","volume":"79","author":"K Ritola","year":"2005","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/JVI.79.3.1772-1788.2005","article-title":"Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.","volume":"79","author":"MC Strain","year":"2005","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.1128\/JVI.79.13.7959-7966.2005","article-title":"Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.","volume":"79","author":"PR Harrington","year":"2005","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.","volume":"373","author":"DD Ho","year":"1995","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection.","volume":"373","author":"X Wei","year":"1995","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrmicro772","article-title":"HIV-1 dynamics in vivo: implications for therapy.","volume":"1","author":"V Simon","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.190065897","article-title":"Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy.","volume":"97","author":"WS Hlavacek","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/QAD.0b013e3282f12377","article-title":"Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.","volume":"21","author":"JM Murray","year":"2007","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1073\/pnas.0711372105","article-title":"Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle.","volume":"105","author":"AR Sedaghat","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1128\/JVI.68.10.6672-6683.1994","article-title":"Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.","volume":"68","author":"EL Delwart","year":"1994","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1126\/science.8235655","article-title":"Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.","volume":"262","author":"EL Delwart","year":"1993","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/JVI.72.1.617-623.1998","article-title":"Human immunodeficiency virus type 1 populations in blood and semen.","volume":"72","author":"EL Delwart","year":"1998","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.virol.2004.09.004","article-title":"HIV-1 populations in blood and breast milk are similar.","volume":"330","author":"GJ Henderson","year":"2004","journal-title":"Virology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/meth.1997.0489","article-title":"Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis.","volume":"12","author":"EL Delwart","year":"1997","journal-title":"Methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1128\/JVI.02554-06","article-title":"Independent evolution of human immunodeficiency virus type 1 env V1\/V2 and V4\/V5 hypervariable regions during chronic infection.","volume":"81","author":"PR Harrington","year":"2007","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1128\/JVI.77.12.6811-6822.2003","article-title":"Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.","volume":"77","author":"KM Kitrinos","year":"2003","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.71.11.8750-8758.1997","article-title":"Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.","volume":"71","author":"JA Nelson","year":"1997","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"10591","DOI":"10.1128\/JVI.00644-06","article-title":"Sequential turnover of human immunodeficiency virus type 1 env throughout the course of infection.","volume":"80","author":"TM Riddle","year":"2006","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1128\/JVI.78.20.11208-11218.2004","article-title":"Multiple V1\/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1.","volume":"78","author":"K Ritola","year":"2004","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1073\/pnas.98.1.176","article-title":"A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.","volume":"98","author":"W Resch","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1128\/JVI.78.13.7112-7123.2004","article-title":"Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA\/DNA heteroduplex generator-tracking assay.","volume":"78","author":"A Kapoor","year":"2004","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.59.6.923","article-title":"Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.","volume":"59","author":"RJ Ellis","year":"2002","journal-title":"Arch Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00415-005-0749-4","article-title":"Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease.","volume":"252","author":"HJ von Giesen","year":"2005","journal-title":"J Neurol"},{"key":"ref47","article-title":"Major co-existing human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.","author":"WL Ince","year":"2009","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-7-37","article-title":"Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.","volume":"7","author":"CM Marra","year":"2007","journal-title":"BMC Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2334-5-98","article-title":"Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.","volume":"5","author":"SS Spudich","year":"2005","journal-title":"BMC Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.","volume":"65","author":"S Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1093\/nar\/gkn713","article-title":"Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes.","volume":"36","author":"G Schnell","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1128\/JVI.77.24.13376-13388.2003","article-title":"Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.","volume":"77","author":"MA Jensen","year":"2003","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.","volume":"10","author":"O Bagasra","year":"1996","journal-title":"AIDS"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410390606","article-title":"Localization of HIV-1 in human brain using polymerase chain reaction\/in situ hybridization and immunocytochemistry.","volume":"39","author":"K Takahashi","year":"1996","journal-title":"Ann Neurol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/00002030-200309050-00008","article-title":"Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.","volume":"17","author":"C Eggers","year":"2003","journal-title":"AIDS"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ana.410280413","article-title":"Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.","volume":"28","author":"BJ Brew","year":"1990","journal-title":"Ann Neurol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11481-006-9035-1","article-title":"Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.","volume":"2","author":"M Gisslen","year":"2007","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","article-title":"CSF neurofilament protein (NFL) \u2013 a marker of active HIV-related neurodegeneration.","volume":"254","author":"S Abdulle","year":"2007","journal-title":"J Neurol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.wnl.0000277635.05973.55","article-title":"Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.","volume":"69","author":"A Mellgren","year":"2007","journal-title":"Neurology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jneuroim.2005.07.002","article-title":"Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.","volume":"168","author":"P Cinque","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2006.06.018","article-title":"Relationship of CSF leukocytosis to compartmentalized changes in MCP-1\/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.","volume":"179","author":"S Monteiro de Almeida","year":"2006","journal-title":"J Neuroimmunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00002030-199811000-00014","article-title":"Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.","volume":"12","author":"P Cinque","year":"1998","journal-title":"AIDS"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.410440521","article-title":"Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.","volume":"44","author":"W Kelder","year":"1998","journal-title":"Ann Neurol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","article-title":"Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.","volume":"63","author":"JJ Sevigny","year":"2004","journal-title":"Neurology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00002030-200107060-00006","article-title":"Cerebrospinal fluid response to structured treatment interruption after virological failure.","volume":"15","author":"RW Price","year":"2001","journal-title":"AIDS"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00042560-199803010-00005","article-title":"Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.","volume":"17","author":"C Martin","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00002030-199906180-00008","article-title":"Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.","volume":"13","author":"S Staprans","year":"1999","journal-title":"AIDS"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/infdis\/158.5.1079","article-title":"The AIDS dementia complex.","volume":"158","author":"RW Price","year":"1988","journal-title":"J Infect Dis"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T22:41:01Z","timestamp":1684968061000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000395"}},"subtitle":[],"editor":[{"given":"Danny C.","family":"Douek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,24]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000395","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,24]]}}}